Evidence map›Paper›PMID 42441797›Full record

ArticleAnalytical chemistry2026

SpecTUS: Spectral Translator for Unknown Structures Annotation from EI-MS Spectra.

Adam Hájek, Michal Starý, Elliott Price, Filip Jozefov, Helge Hecht, Aleš Křenek

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam HájekInstitute of Computer Science, Masaryk University, Šumavská 525/33, Brno602 00, Czech Republic.
Michal StarýSchool of Computation, Information and Technology, Technical University Munich, Boltzmannstraße 3, Garching bei München85748, Germany.
Elliott PriceRECETOX, Masaryk University, Kamenice 753/5, Brno625 00, Czech Republic.
Filip JozefovFaculty of Informatics, Masaryk University, Botanická 554/68a, Brno602 00, Czech Republic.
Helge HechtRECETOX, Masaryk University, Kamenice 753/5, Brno625 00, Czech Republic.ORCID 0000-0001-6744-996X
Aleš KřenekInstitute of Computer Science, Masaryk University, Šumavská 525/33, Brno602 00, Czech Republic.ORCID 0000-0002-3395-3196

Funding

Horizon 2020 Framework Programme 857560Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy LM2023054Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy LM2023069
6 · The paper itself

Abstract

Compound identification and structure annotation from mass spectra are essential in drug detection, forensics, and small molecule discovery. Current approaches to compound identification from electron ionization mass spectra (EI-MS) are dependent on different forms of searching databases that are orders of magnitude smaller than the space of potential molecular structures they attempt to cover. We introduce SpecTUS: Spectral Translator for Unknown Structures, a deep learning model for de novo structural annotation, translating gas chromatography EI-MS spectra directly into molecular structures without requiring reference databases. This enables the identification of novel compounds absent from spectral libraries. In a rigorous evaluation, SpecTUS significantly outperformed standard database search techniques. On a held-out test set of 28,267 spectra from NIST 20, the model's single suggestion perfectly reconstructed 43% of the subset's compounds. On 76% of this test set, the single suggestion is strictly better, in terms of Tanimoto similarity of Morgan fingerprint, than the result of hybrid database search. With ten suggestions, SpecTUS achieved 65% perfect reconstructions, surpassing hybrid search on 84% of the test set.

Identifiers

PMID42441797
PMCPMC13425552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.